Actions and Detail Panel
A New, Non-Toxic & Effective Pharmacological Treatment of Cancer
Sat, April 22, 2017, 2:00 PM – 3:00 PM PDT
Renowned American Cancer Scientist To Discuss A New and Effective Treatment For Cancer Patients At UBC Robson Square
Dr. Frank Arguello
Director, Atavistic Chemotherapy Clinical Trial
Frm. Assistant Professor of Oncology, and Pediatrics Hem/Onc., University of Rochester School of Medicine and Dentistry. Rochester, New York USA.
Frm. Senior Scientist, Division of Cancer Treatment,
Drug Discovery, Research and Development.
National Cancer Institute, National Institutes of Health. Frederick, Maryland USA.
WHY AND WHO SHOULD ATTEND?
Despite advances in cancer research and treatment, cancer is threatening society now more than ever in recorded history. To better appreciate the magnitude of this crisis, in 2013, an estimated 8.2 million cancer deaths occurred worldwide (100,000 of them being children). By 2030, this number will double to 17 million (Reference).
In Canada, it is the leading cause of death across all provinces. (Reference). With few exceptions, cancers that are deemed inoperable or have spread to other organs (metastasized) remain incurable and lethal. Unaware of this, the great majority of cancer patients in the US with inoperable or metastatic cancers accept to endure the side effects of traditional chemotherapy without seeking out other treatment options. Unfortunately, these patients eventually succumb to their disease (Reference).
Dr. Frank Arguello, M.D., a former Assistant Prof. of Oncology, Pediatrics Hematology, and Oncology at the University of Rochester School of Medicine & Dentistry and a former Senior Scientist at the Division of Cancer Treatment, Drug Discovery, Research and Development. National Cancer Institute, National Institutes of Health in Maryland, is the current Director of the Atavistic Chemotherapy Clinical Trial where, since 2011, has been researching, evaluating and implementing a new, revolutionary approach to cancer treatment known as “Atavistic Chemotherapy”. The results of which are likely to change the way we understand and treat cancer in the world moving forward.
Armed with this new, non-toxic and effective treatment option, Dr. Arguello would like to invite those currently struggling with a cancer diagnosis, local oncologists or concerned family members and friends to attend a free one-hour conference at 2pm on Saturday, April 22nd, 2017 at UBC Robson Square where he will share his research, findings and patient success stories and discuss trial participation options.
Past patient, Barbara Hall just shared this piece with us regarding her cancer story, and success she found working with Dr. Arguello. https://storify.com/AtavisticChemo/how-i-survived-stage-4-metastatic-melanoma-brain-t
This clinical trial is registered with the U.S. National Institutes of health since 2011
DATE: Saturday, April 22, 2017
TIME: 2:00 PM - 3:00 PM
Doors: 1:30 PM Light refreshments provided
COST: FREE to register and attend
UBC Robson Square
800 Robson St.
To register for FREE or inquire, please visit: www.atavisticchemotherapy.com